Pui CH, Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov. 2007;6(2):149–65.

Article  CAS  PubMed  Google Scholar 

Roberts K, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371(11):1005–15.

Article  PubMed  PubMed Central  Google Scholar 

Herold T, Schneider S, Metzeler K, et al. Philadelphia chromosome-like acute lymphoblastic leukemia in adults have frequent IGH-CRLF2 and JAK 2 mutations, persistence of minimal residual disease and poor prognosis. Haematologica. 2017;102(1):130–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ravandi F, O’Brien S, Cortes J, et al. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer. 2015;121(23):4158–64.

Article  CAS  PubMed  Google Scholar 

Pui C, Roberts K, Yang J, et al. Philadelphia chromosome-like acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2017;17(8):464–70.

Article  PubMed  PubMed Central  Google Scholar 

Sánchez R, Ribera J, Morgades M, et al. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics. Blood Cancer J. 2020;10(4):1–11.

Article  Google Scholar 

Rivera G, Pui C, Hancock M, et al. Update of St Jude study XI for childhood acute lymphoblastic leukemia. Leukemia. 1992;6(2):153–6.

PubMed  Google Scholar 

DeAngelo D, Stevenson K, Dahlberg S, et al. Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia. Leukemia. 2015;29(3):526–34.

Article  CAS  PubMed  Google Scholar 

Kantarjian H, Thomas D, O’Brien S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004;101(12):2788–801.

Article  CAS  PubMed  Google Scholar 

Alvarnas J, Brown P, Aoun P, et al. Acute Lymphoblastic Leukemia. J Natl Compr Cancer Netw. 2015;2(13):1240–79.

Article  Google Scholar 

Swerdlow S, Campo E, Harris N, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arber D, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

Article  CAS  PubMed  Google Scholar 

Hess L, Brnabic A, Mason O, et al. Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology. J Cancer. 2019;10(16):3717–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Layla S, Nour D, Sherin A, et al. High CRLF2 Expression Could Identify Acute Lymphoblastic Leukemia Patients with Poor Outcome but Not IKZF1. Res Oncol. 2021;17(1):23–30.

Google Scholar 

Jain N, Kathryn G, Jabbour E, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129(5):572–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Konoplev S, Lu X, Konopleva M, et al. CRLF2-Positive B‑Cell Acute Lymphoblastic Leukemia in Adult Patients A Single-Institution Experience. Am J Clin Pathol. 2017;147:357–63.

Article  CAS  PubMed  Google Scholar 

Herold T, Baldus C, Gökbuget N. Ph-like acute lymphoblastic leukemia in older adults. N Engl J Med. 2014;371(23):2235.

Article  PubMed  Google Scholar 

Boer J, Koenders J, van der Holt B, et al. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates. Haematologica. 2015;100(7):261–4.

Article  Google Scholar 

Vesely C, Frech C, Eckert C, et al. Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia. Leukemia. 2017;31(7):1491–501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rowe J, Buck G, Chopra R, et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood. 2005;106(12):3760–7.

Article  CAS  PubMed  Google Scholar